Journal of Family Medicine and Primary Care (Jan 2022)

Role of 25-hydroxyvitamin D in irritable bowel syndrome patients

  • Haris Alvi,
  • Gohar Ali,
  • Sadia Iqbal,
  • Muhammad Nadeem Ahsan,
  • Avinash,
  • Muhammad Ali Siddiqui,
  • Tooba Ahmed Kirmani,
  • Ghazala Irshad,
  • Haisum Baktashi,
  • Muhammad Sohaib Asghar

DOI
https://doi.org/10.4103/jfmpc.jfmpc_1336_22
Journal volume & issue
Vol. 11, no. 12
pp. 7975 – 7978

Abstract

Read online

We conducted this study on patients diagnosed with irritable bowel syndrome without identifiable stressors and replaced them with vitamin D supplements for 3 months. Almost 97 cases have repeated the vitamin D status that appeared to be sufficient, while 14 patients were missing data for follow-up. The advised option was intramuscular injection replacement but 34 out of 97 were taken oral route for replacement of Vitamin D and incidental finding is noted that serum vitamin D levels rise less in the oral group than in the intramuscular group. Mean age of our subjects was 35.97 ± 9.89 years, comprising 54% males (n = 60) and 46% females (n = 51). In the outcomes of our study, 56.7% of individuals showed complete relief from IBS symptoms after vitamin D replacement, while 36.1% reported considerable improvement. Another 6.2% had exhibited moderate relief with about 14 individuals lost to follow-up.

Keywords